"Informed AI News" is an publications aggregation platform, ensuring you only gain the most valuable information, to eliminate information asymmetry and break through the limits of information cocoons. Find out more >>
Biden Administration Cuts Medicare Drug Prices, Promises Billions in Savings
- summary
- score
Biden's team has just reduced prices on 10 key drugs. Medicare now negotiates directly with drug manufacturers. This initiative, starting in 2026, aims to save $6 billion for Medicare and $1.5 billion for patients.
Here's the breakdown:
- Eliquis: $231 (previously $521)
- Jardiance: $197 (previously $573)
- Xarelto: $197 (previously $517)
- Januvia: $113 (previously $527)
- Farxiga: $178.50 (previously $556)
- Entresto: $295 (previously $628)
- Enbrel: $2,355 (previously $7,106)
- Imbruvica: $9,319 (previously $14,934)
- Stelara: $4,695 (previously $13,836)
- Fiasp and NovoLog: $119 (previously $495)
These price cuts are significant. They could lead to healthier, longer lives for many. The Inflation Reduction Act, which enabled these negotiations, marks a first in Medicare's history.
The actual impact? It's difficult to pinpoint exactly. Drug prices are often obscured by confidential rebates. However, these new rates establish a benchmark. More negotiations are forthcoming.
This move is not just about saving money. It's about ensuring access. It's about making sure older Americans can afford the medications they need.
| Scores | Value | Explanation |
|---|---|---|
| Objectivity | 5 | Balanced reporting with factual support. |
| Social Impact | 5 | Significantly influences public opinion on healthcare costs. |
| Credibility | 5 | Solid evidence from authoritative sources. |
| Potential | 5 | High potential to trigger broader healthcare policy discussions. |
| Practicality | 5 | Directly applicable to real healthcare cost issues. |
| Entertainment Value | 2 | Contains few entertaining elements. |